logo
Share SHARE
FONT-SIZE Plus   Neg

Glenmark Generics Receives Approval For Hydrocortisone Butyrate Cream USP, 0.1%

Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. had received the approval from US FDA for Hydrocortisone Butyrate Cream USP, 0.1 percent, abbreviated new drug approval (ANDA), a generic version of Locoid Lipocream.

In April 2011, Glenmark had entered into a royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV to settle a patent infringement suit against the commercialization of generic version of Locoid Lipocream and agreed to launch in near the end of CY2013. Glenmark is entitled to 180 days of exclusivity with respect to its Hydrocortisone Butyrate Cream, as it is the first generic company to file an ANDA for the product.

Hydrocortisone Butyrate Cream is indicted for the Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and the treatment of mild to moderate atopic dermatitis in patients 3 months to 18 years of age.

According to ISM Health sales data, Hydrocortisone Butyrate Cream had sales of around $34 million for the 12 months ended June 30, 2013.

AT the BSE, Glenmark Pharmaceuticals shares are currently trading at Rs.530.95, up 1.55 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British integrated oil and gas major BP Plc. (BP.L, BP_UN.TO, BP) Tuesday announced a narrower replacement cost loss for the second quarter from the prior year. Revenues were hit by lower oil prices. The company said the results draws a line under Deepwater Horizon liabilities, despite strong operations... Telecommunications giant Verizon Communications, Inc. on Tuesday an 83 percent plunge in profit for the second quarter from last year on lower revenues and higher expenses. However, adjusted earnings per share for the quarter topped analysts' expectations, while revenues missed their estimates. Telecommunications giant Verizon Communications, Inc. on Tuesday an 83 percent plunge in profit for the second quarter from last year on lower revenues and higher expenses. However, adjusted earnings per share for the quarter topped analysts' expectations, while revenues missed their estimates.
comments powered by Disqus
Follow RTT